Tyrosine kinase 3D structures
From Proteopedia
(Difference between revisions)
(10 intermediate revisions not shown.) | |||
Line 5: | Line 5: | ||
*'''NON-RECEPTOR TYROSINE KINASES - nRTK''' | *'''NON-RECEPTOR TYROSINE KINASES - nRTK''' | ||
+ | |||
+ | *'''Fyn tyrosine kinase''' (Domains: SH3 80-141; SH2 142-247; kinase 260-537) | ||
+ | |||
+ | **[[1shf]], [[3ua6]], [[7a2j]], [[7a2k]] – hTK Fyn SH3 domain – human<br /> | ||
+ | **[[3h0f]], [[3h0h]], [[3h0i]], [[3cqt]], [[6ipz]], [[6ipy]], [[7a2l]], [[7a2m]], [[7a2n]], [[7a2o]], [[7a2p]], [[7a2q]], [[7a2r]],[[7a2s]], [[7a2t]], [[7a2u]], [[7a2v]] - hTK Fyn SH3 domain (mutant)<br /> | ||
+ | **[[1zbj]] - hTK Fyn SH3 domain – NMR<br /> | ||
+ | **[[1g83]] - hTK Fyn SH2+SH3 domains (mutant)<br /> | ||
+ | **[[6edf]] - hTK Fyn residues 1-77<br /> | ||
+ | **[[3uf4]] – mTK Fyn SH3-SH2 domain – mouse<br /> | ||
+ | **[[3uf4]] - mTK Fyn SH2+SH3 domains<br /> | ||
+ | **[[2l2p]], [[2lp5]] - cTK Fyn SH3 domain (mutant)- chicken - NMR<br /> | ||
+ | |||
+ | *Fyn complex | ||
+ | |||
+ | **[[1fyn]], [[4znx]] - hTK Fyn SH3 domain + peptide<br /> | ||
+ | **[[1a0n]], [[1azg]], [[1nyf]], [[1nyg]] - hTK Fyn SH3 domain + peptide – NMR<br /> | ||
+ | **[[1avz]], [[1efn]] - hTK Fyn SH3 domain + HIV Nef protein<br /> | ||
+ | **[[4d8d]], [[7d7s]] - hTK Fyn SH3 domain (mutant) + HIV Nef protein<br /> | ||
+ | **[[1m27]] - hTK Fyn SH3 domain + SH2 domain protein 1A + SLAM peptide<br /> | ||
+ | **[[4d8d]] - hTK Fyn SH3 domain (mutant) + HIV Nef protein<br /> | ||
+ | **[[3ua7]] – hTK Fyn SH3 domain + hepatitis virus peptide<br /> | ||
+ | **[[4eik]] - hTK Fyn SH3 domain + VSL12 peptide<br /> | ||
+ | **[[7a2w]], [[7a2x]], [[7a2y]], [[7a2z]] - hTK Fyn SH3 domain (mutant) + VSL12 peptide<br /> | ||
+ | **[[1aot]], [[1aou]] - hTK Fyn SH2 domain + phosphopeptide - NMR<BR /> | ||
+ | **[[2dq7]] – hTK kinase domain + staurosporine<br /> | ||
*'''Abelson tyrosine kinase''' | *'''Abelson tyrosine kinase''' | ||
Line 16: | Line 41: | ||
**[[5oaz]] - hTK SH3 domain <br /> | **[[5oaz]] - hTK SH3 domain <br /> | ||
+ | **[[7pw2]] - hTK SH3 domain (mutant) <br /> | ||
**[[1ju5]] - hTK SH3 domain (mutant) + CRK SH2 domain + phosphopeptide - NMR<br /> | **[[1ju5]] - hTK SH3 domain (mutant) + CRK SH2 domain + phosphopeptide - NMR<br /> | ||
**[[1awo]] - hTK SH3 domain + phosphopeptide – NMR<BR /> | **[[1awo]] - hTK SH3 domain + phosphopeptide – NMR<BR /> | ||
Line 21: | Line 47: | ||
**[[2o88]] - hTK SH3 domain (mutant} + peptide<br /> | **[[2o88]] - hTK SH3 domain (mutant} + peptide<br /> | ||
**[[4jjb]], [[4jjc]], [[4jjd]] - hTK abl SH3 domain <br /> | **[[4jjb]], [[4jjc]], [[4jjd]] - hTK abl SH3 domain <br /> | ||
- | **[[ | + | **[[3eg0]], [[3eg1]], [[3eg2]], [[3eg3]], [[3egu]], [[4j9b]] - hTK abl SH3 domain (mutant)<br /> |
**[[4j9c]], [[4j9e]], [[4j9i]] - hTK abl SH3 domain (mutant) + p17 peptide<br /> | **[[4j9c]], [[4j9e]], [[4j9i]] - hTK abl SH3 domain (mutant) + p17 peptide<br /> | ||
**[[4j9d]], [[4j9f]] - hTK abl SH3 domain (mutant) + p0 peptide<br /> | **[[4j9d]], [[4j9f]] - hTK abl SH3 domain (mutant) + p0 peptide<br /> | ||
Line 41: | Line 67: | ||
**[[6bl8]] - hTK kinase domain<br /> | **[[6bl8]] - hTK kinase domain<br /> | ||
**[[2g2h]] - hTK kinase domain (mutant)<br /> | **[[2g2h]] - hTK kinase domain (mutant)<br /> | ||
- | **[[ | + | **[[6xr6]], [[6xr7]], [[6xrg]] - hTK kinase domain (mutant) - NMR<br /> |
**[[2g1t]] - hTK kinase domain + peptide<br /> | **[[2g1t]] - hTK kinase domain + peptide<br /> | ||
- | **[[ | + | **[[2g2f]], [[2g2i]] - hTK kinase domain (mutant) + peptide<br /> |
- | **[[ | + | **[[2gqg]], [[2hzi]], [[2hz4]], [[2hz0]], [[2hyy]], [[3cs9]], [[3ue4]], [[4wa9]], [[7n9g]] - hTK kinase domain + cancer drug<br /> |
**[[2f4j]], [[4twp]] - hTK kinase domain (mutant) + cancer drug<br /> | **[[2f4j]], [[4twp]] - hTK kinase domain (mutant) + cancer drug<br /> | ||
- | **[[ | + | **[[2e2b]], [[2hiw]], [[2v7a]], [[3qrk]], [[3qri]], [[3qrj]], [[4zog]], [[5hu9]], [[4yc8]], [[3pyy]], [[6npv]], [[6npu]], [[6npe]], [[7cc2]], [[7dt2]], [[7w7x]], [[7w7y]] - hTK kinase domain + inhibitor<br /> |
**[[1opj]], [[1opk]] - mTK kinase domain <br /> | **[[1opj]], [[1opk]] - mTK kinase domain <br /> | ||
**[[1fpu]], [[1m52]], [[2qoh]], [[3kf4]], [[3kfa]] - mTK kinase domain + inhibitor<br /> | **[[1fpu]], [[1m52]], [[2qoh]], [[3kf4]], [[3kfa]] - mTK kinase domain + inhibitor<br /> | ||
Line 65: | Line 91: | ||
**[[1zzp]] - hTK abl F-actin binding domain – NMR <br /> | **[[1zzp]] - hTK abl F-actin binding domain – NMR <br /> | ||
- | |||
- | *Abl2 SH3 domain residues 110-166 | ||
- | |||
- | **[[5np3]] - hTK SH3 domain <BR /> | ||
- | **[[5np5]], [[5np2]] - hTK SH3 domain + phosphonotyrosine<BR /> | ||
*Abl2 SH2 domain residues 165-273 | *Abl2 SH2 domain residues 165-273 | ||
Line 86: | Line 107: | ||
**[[2kk1]] – hTK C terminal – NMR<BR /> | **[[2kk1]] – hTK C terminal – NMR<BR /> | ||
- | *''' | + | *'''Csk tyrosine kinase''' |
- | **[[ | + | **[[3eac]] - hTK SH2 domain<br /> |
- | **[[ | + | **[[3eaz]] - hTK SH2 domain (mutant)<br /> |
- | **[[ | + | **[[2rsy]] - hTK SH2 domain + CBP phosphopeptide - NMR<br /> |
- | **[[ | + | **[[1csk]] - hTK SH3 domain<br /> |
+ | **[[1jeg]] - hTK SH3 domain + tyrosine phosphatase peptide - NMR<br /> | ||
+ | **[[1byg]] - hTK kinase domain + staurosporine<br /> | ||
+ | **[[3d7t]], [[3d7u]] - hTK kinase domain (mutant) + C-Src<br /> | ||
+ | **[[1k9a]] - TK C terminal - rat<br /> | ||
- | *''' | + | *'''Fgr tyrosine kinase''' |
- | **[[ | + | **[[7uy0]] - hTK 80-527 + inhibitor<br /> |
- | + | **[[7uy3]] - hTK 80-527 (mutant) + inhibitor<br /> | |
- | + | **[[7jt9]] - hTK SH3 domain 77-138<br /> | |
- | **[[ | + | |
- | **[[ | + | |
- | + | ||
- | *''' | + | *'''Jak tyrosine kinase''' see [[Janus kinase]] |
- | * | + | *'''p55-blk tyrosine kinase''' |
- | + | ||
- | * | + | **[[1blj]], [[1blk]] - mTK p55-blk SH2 domain – NMR<BR /> |
- | * | + | * '''Src tyrosine kinase''' or proto-oncogene tyrosine protein kinase (Domains: SH3 85-140; SH2 140-251; kinase 253-535) |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | * | + | *Src tyrosine kinase SH2 domain |
- | **[[ | + | **[[3eac]] - hTK <br /> |
+ | **[[4f59]], [[3eaz]] - hTK (mutant) <br /> | ||
+ | **[[4f5b]] - hTK (mutant) + phosphotyrosine<br /> | ||
+ | **[[4f5a]] - hTK (mutant) + phosphate<br /> | ||
+ | **[[1o4c]] - hTK + phosphate<br /> | ||
+ | **[[1o41]], [[1o42]], [[1o43]], [[1o44]], [[1o45]], [[1o46]], [[1o47]], [[1o48]], [[1o49]], [[1o4a]], [[1o4b]], [[1o4d]], [[1o4e]], [[1o4f]], [[1o4g]], [[1o4h]], [[1o4i]], [[1o4j]], [[1o4k]], [[1o4l]], [[1o4m]], [[1o4n]], [[1o4o]], [[1o4p]], [[1o4q]], [[1o4r]] - hTK + inhibitor<br /> | ||
+ | **[[1hcs]], [[1hct]] - hTK + peptide - NMR<br /> | ||
+ | **[[1a07]], [[1a08]], [[1a09]], [[1a1a]], [[1a1b]], [[1a1c]], [[1a1e]] - hTK + peptide <br /> | ||
+ | **[[1f2f]] - cTK (mutant) <br /> | ||
+ | **[[1shd]] - cTK + TRKA receptor<br /> | ||
+ | **[[1p13]] - cTK + peptide<br /> | ||
+ | **[[1f1w]] - cTK (mutant) + peptide<br /> | ||
+ | **[[1spr]] - RsvTK + phosphate – Rous sarcoma virus<br /> | ||
+ | **[[2jyq]] – RsvTK – NMR<br /> | ||
+ | **[[1kc2]], [[1is0]], [[1nzl]], [[1nzv]], [[1sps]] - RsvTK + peptide<br /> | ||
+ | **[[1sha]], [[1shb]] - RsvTK + phosphopeptide<br /> | ||
+ | **[[1qwe]], [[1qwf]] - RsvTK + peptide<br /> | ||
- | * | + | *Src tyrosine kinase SH3 domain |
- | **[[ | + | **[[6c4s]] – hTK + choline kinase peptide<br /> |
- | **[[ | + | **[[1jeg]] – mTK + protein-tyrosine phosphatase peptide<br /> |
+ | **[[1srl]], [[1srm]] - cTK – NMR<br /> | ||
+ | **[[3fj5]], [[4jz3]], [[4jz4]], [[6xvo]], [[6xvn]] - cTK<br /> | ||
+ | **[[4le9]], [[4oml]], [[4omm]], [[4omn]], [[4omo]], [[4omp]], [[4omq]], [[4rtu]], [[4rtx]], [[5i11]], [[7a30]], [[7a31]], [[7a32]], [[7a33]], [[7a34]], [[7a35]], [[7a36]], [[7a37]], [[7a38]], [[7a39]], [[7a3a]], [[7a3b]], [[7a3c]], [[7a3d]], [[7a3e]], [[7ner]], [[7nes]], [[7net]] - cTK (mutant) <br /> | ||
+ | **[[6xx3]], [[6xx2]], [[6xx5]], [[6xx4]], [[6xx5]], [[6xx2]] - cTK (mutant) + ion<br /> | ||
+ | **[[2pri]], [[4hxj]], [[4qt7]], [[4rty]], [[4rtz]] - cTK + peptide<br /> | ||
+ | **[[1prm]], [[1rlp]], [[1rlq]], [[1nlo]], [[1nlp]] - cTK + peptide - NMR<br /> | ||
+ | **[[4hvu]], [[4hvv]], [[4hvw]], [[4rtv]], [[4rtw]], [[5ob2]], [[5ob1]], [[5ob0]], [[5oav]] - cTK (mutant) + peptide<br /> | ||
+ | **[[4y92]] - TK (mutant) - Avian sarcoma virus<br /> | ||
- | * | + | *Src tyrosine kinase kinase domain residues 253-535 |
- | **[[ | + | **[[1yo6]] - hTK <br /> |
- | **[[ | + | **[[1yoj]] - hTK (mutant) <br /> |
- | **[[ | + | **[[2bdf]], [[2bdj]], [[6e6e]], [[6ate]], [[7ng7]] – hTK + inhibitor<br /> |
- | **[[ | + | **[[1yol]], [[1yom]] – hTK (mutant) + inhibitor<br /> |
- | **[[ | + | **[[1byg]] – hTK + staurosporine<br /> |
- | **[[ | + | **[[4mxo]] – hTK + cancer drug<br /> |
+ | **[[4mxx]], [[4mxy]], [[4mxz]] – hTK (mutant) + cancer drug<br /> | ||
+ | **[[3of0]], [[2qi8]] - cTK (mutant) <br /> | ||
+ | **[[3d7t]], [[3d7u]] – cTK + Csk<br /> | ||
+ | **[[3dqw]], [[3dqx]] - cTK (mutant) + ATP<br /> | ||
+ | **[[3tz7]], [[3tz8]], [[3tz9]], [[4dgg]] – cTK (mutant) + pyrazolin derivative<br /> | ||
+ | **[[4fic]], [[3uqg]], [[3uqf]], [[3u51]], [[3u4w]], [[4agw]], [[3qlg]], [[3qlf]], [[3g6g]], [[3el8]], [[3f6x]], [[2hwo]], [[2hwp]], [[2oiq]], [[3en4]], [[3en5]], [[3en6]], [[3en7]], [[3el7]], [[5bmm]], [[5j5s]], [[4ybj]], [[4ybk]], [[5xp7]], [[7ah3]], [[7d57]], [[7d5o]] – cTK + inhibitor<br /> | ||
+ | **[[7wf5]] – cTK + cancer drug<br /> | ||
+ | **[[4lgg]], [[4lgh]], [[3svv]], [[3oez]], [[3lok]], [[3g5d]], [[3f3w]], [[3f3v]], [[3geq]], [[3g6h]], [[3f3t]], [[3f3u]], [[2qlq]], [[2qq7]], [[4lgg]], [[4lgh]], [[4mcv]], [[4o2p]], [[5teh]], [[5t0p]], [[5sys]], [[5swh]], [[6hve]], [[6hvf]] – cTK (mutant) + inhibitor<br /> | ||
+ | **[[4u5j]] – cTK (mutant) + cancer drug<br /> | ||
- | * | + | *Src tyrosine kinase C terminal domain |
- | **[[ | + | **[[1k9a]] – rTK <br /> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | * | + | *Src tyrosine kinase SH2+SH3+kinase domains residues 85-535 |
- | **[[ | + | **[[1ksw]] – hTK (mutant)+ ADP derivative<br /> |
- | + | **[[1y57]] – hTK + inhibitor<br /> | |
- | + | **[[4k11]] – hTK (mutant) + inhibitor<br /> | |
- | + | **[[6f3f]] – mTK + ADP <br /> | |
- | + | ||
- | **[[ | + | |
- | **[[ | + | |
- | **[[ | + | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | * | + | *Src tyrosine kinase SH2+SH3+kinase+C terminal domains |
- | **[[ | + | **[[1fmk]] – hTK <br /> |
- | + | **[[2src]] – hTK + AMPPNP<br /> | |
- | + | **[[2ptk]] – cTK <br /> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | **[[ | + | |
- | + | ||
- | **[[ | + | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | * | + | *Src tyrosine kinase N terminal+SH2+SH3+kinase domains |
- | **[[ | + | **[[2h8h]] – hTK + inhibitor<br /> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
*'''Lymphocyte-specific tyrosine kinase Lck''' (Domains: SH3 58-118; SH2 122-225; kinase 230-500) | *'''Lymphocyte-specific tyrosine kinase Lck''' (Domains: SH3 58-118; SH2 122-225; kinase 230-500) | ||
Line 221: | Line 222: | ||
**[[1x27]] - hTK Lck SH3-SH2 domain + peptide<br /> | **[[1x27]] - hTK Lck SH3-SH2 domain + peptide<br /> | ||
**[[1qpj]] - hTK Lck kinase domain + staurosporin<br /> | **[[1qpj]] - hTK Lck kinase domain + staurosporin<br /> | ||
- | **[[ | + | **[[1qpc]], [[1qpd]], [[1qpe]], [[2of2]], [[2of4]], [[2ofu]], [[2ofv]], [[2og8]], [[2zm1]], [[2zm4]], [[2zyb]], [[3ac1]], [[3ac2]], [[3ac3]], [[3ac4]], [[3ac5]], [[3ac8]], [[3acj]], [[3ack]], [[3ad4]], [[3ad5]], [[3ad6]], [[3b2w]], [[3bym]], [[3bys]], [[3byu]], [[3byo]], [[3kmm]], [[6pdj]] - hTK Lck kinase domain + inhibitor<br /> |
**[[3mpm]] - hTK Lck kinase domain (mutant) + inhibitor<br /> | **[[3mpm]] - hTK Lck kinase domain (mutant) + inhibitor<br /> | ||
**[[4c3f]] - hTK Lck kinase domain (mutant) + chemotype<br /> | **[[4c3f]] - hTK Lck kinase domain (mutant) + chemotype<br /> | ||
Line 229: | Line 230: | ||
**[[1q69]] - hTK Lck residues 6-34 (mutant) + CD8 – NMR<br /> | **[[1q69]] - hTK Lck residues 6-34 (mutant) + CD8 – NMR<br /> | ||
- | *''' | + | *'''Syk - spleen tyrosine kinase''' |
- | **[[ | + | **[[1xba]], [[4xg2]] – hSyk kinase domain residues 337-635 |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | * | + | *Syk complex |
- | **[[ | + | **[[1xbb]] - hSyk kinase domain + Gleevec<br /> |
+ | **[[1xbc]] - hSyk kinase domain + staurosporine<br /> | ||
+ | **[[3emg]], [[3fqe]], [[3fqh]], [[3fqs]], [[3srv]], [[3tub]], [[3tuc]], [[3tud]], [[3vf8]], [[3vf9]], [[4dfl]], [[4dfn]], [[4f4p]], [[4fyn]], [[4fyo]], [[4fz6]], [[4fz7]], [[4gfg]], [[4i0r]], [[4i0s]], [[4i0t]], [[4puz]], [[4pv0]], [[4rx7]], [[4rx8]], [[4rx9]], [[4wnm]], [[4xg3]], [[4xg4]], [[4xg6]], [[4xg7]], [[4xg8]], [[4xg9]], [[4rss]], [[4yjo]], [[4yjp]], [[4yjq]], [[4yjr]], [[4yjs]], [[4yjt]], [[4yju]], [[4yjv]], [[5c26]], [[5c27]], [[5ghv]], [[5lma]], [[5lmb]], [[5tr6]], [[5tt7]], [[5tiu]], [[5t68]], [[5y5t]], [[5y5u]], [[6hm6]], [[6hm7]], [[6vov]], [[6zc0]], [[6zcp]], [[6zcq]], [[6zcr]], [[6zcs]], [[6zcu]], [[6zcx]], [[6zcy]], [[8bi2]] - hSyk kinase domain + inhibitor<br /> | ||
+ | **[[4px6]], [[5cxh]], [[5cxz]], [[5cy3]] - hSyk kinase domain (mutant) + inhibitor<br /> | ||
+ | **[[1csy]], [[1csz]] - hSyk SH2 domain + phosphopeptide – NMR<BR /> | ||
+ | **[[4fl1]], [[4fl2]] - hSyk kinase domain + ANP<br /> | ||
+ | **[[4fl3]] - hSyk kinase domain (mutant) + ANP<br /> | ||
+ | **[[7q63]], [[7sa7]] – hSyk tandem SH2 domain <br /> | ||
+ | **[[1a81]], [[7q5t]], [[7q5u]], [[7q5w]] – hSyk tandem SH2 domain + T-cell surface peptide <br /> | ||
- | *''' | + | *'''Itk/Tsk tyrosine kinase''' or interleukin-2 tyrosine kinase; domains – SH2 236-344; SH3 160-236; kinase 357-620 |
- | **[[ | + | **[[2etz]], [[2eu0]] – hTK Itk SH2 domain + phosphopeptide – NMR<BR /> |
- | **[[ | + | **[[2yuq]], [[2lmj]] – hTK Itk SH3 domain – NMR<BR /> |
- | **[[ | + | **[[1sm2]], [[1snu]], [[1snx]] – hTK Itk kinase domain <BR /> |
- | **[[ | + | **[[3miy]] – hTK Itk kinase domain + cancer drug<BR /> |
- | **[[ | + | **[[3v5j]], [[3v5l]], [[3v8t]], [[3v8w]] – hTK Itk kinase domain + inhibitor<BR /> |
+ | **[[3mj1]], [[3mj2]], [[3qgw]], [[3qgy]], [[4hct]], [[4hcu]], [[4hcv]], [[4kio]] – hTK Itk kinase domain (mutant) + inhibitor<BR /> | ||
+ | **[[3t9t]] – hTK Itk kinase domain (mutant) + arthritis drug<BR /> | ||
+ | **[[2e6i]] – hTK Itk BTK motif – NMR<BR /> | ||
+ | **[[4l7s]], [[4m0y]], [[4m0z]], [[4m12]], [[4m13]], [[4m14]], [[4m15]], [[4mf0]], [[4mf1]], [[3v5j]], [[3v5l]], [[3v8t]], [[3v8w]] - hTK Itk kinase domain + inhibitor<br /> | ||
+ | **[[4pp9]], [[4ppa]], [[4ppb]], [[4ppc]], [[4pqn]], [[4qd6]], [[4rfm]], [[4kio]] - hTK Itk kinase domain (mutant) + inhibitor<br /> | ||
+ | **[[1lui]], [[1luk]], [[1lum]], [[1lun]] – mTK Itk SH2 domain – NMR<BR /> | ||
+ | **[[3s9k]] – mTK Itk SH2 domain <BR /> | ||
+ | **[[1awj]], [[2rn8]], [[2rna]] – mTK Itk SH3 domain – NMR<BR /> | ||
+ | **[[2k79]], [[2k7a]] – mTK Itk SH2+SH3 domains – NMR<BR /> | ||
- | *''' | + | *'''Zap-70 tyrosine kinase''' (Domains: SH2 1-259; kinase 327-606 |
- | **[[ | + | **[[4k2r]] – hTK Zap-70<br /> |
+ | **[[2ozo]] - hTK Zap-70 (mutant) <br /> | ||
+ | **[[1m61]] - hTK Zap-70 SH2 domain | ||
- | * | + | *Zap-70 complex |
- | **[[ | + | **[[2oq1]], [[4xz1]] - hTK Zap-70 SH2 domain + peptide<br /> |
+ | **[[4xz0]] - hTK Zap-70 SH2 domain + inhibitor<br /> | ||
+ | **[[1u59]] - hTK Zap-70 kinase domain + staurosporine | ||
- | *'''Pyk2 tyrosine kinase or protein-tyrosine kinase 2-β (Domains: kinase 414-692; FAT 861-1009)''' | + | *'''Pyk2 tyrosine kinase or or protein-tyrosine kinase 2-β (Domains: kinase 414-692; FAT 861-1009)''' |
**[[3cc6]], [[3fzo]] - hTK Pyk2 kinase domain <br /> | **[[3cc6]], [[3fzo]] - hTK Pyk2 kinase domain <br /> | ||
Line 273: | Line 286: | ||
**[[3fzp]] - hTK Pyk2 kinase domain + ATPγS<br /> | **[[3fzp]] - hTK Pyk2 kinase domain + ATPγS<br /> | ||
- | **[[ | + | **[[3et7]], [[3fzr]], [[3fzs]], [[3fzt]], [[3h3c]], [[4h1j]], [[4h1m]], [[5to8]], [[5tob]] - hTK Pyk2 kinase domain + inhibitor<br /> |
**[[3gm1]], [[4r32]] - hTK Pyk2 FAT domain + paxillin peptide<br /> | **[[3gm1]], [[4r32]] - hTK Pyk2 FAT domain + paxillin peptide<br /> | ||
- | **[[ | + | **[[4xef]], [[4xek]], [[4xev]] - hTK Pyk2 FAT domain + leupaxin peptide<br /> |
**[[4h1j]] - hFAK2 kinase domain + pyrazole inhibitor<br /> | **[[4h1j]] - hFAK2 kinase domain + pyrazole inhibitor<br /> | ||
**[[3h3c]] - hFAK2 kinase domain + pyrimidine inhibitor<br /> | **[[3h3c]] - hFAK2 kinase domain + pyrimidine inhibitor<br /> | ||
Line 281: | Line 294: | ||
**[[3u3f]] – hFAK2 FAT domain (mutant) + paxillin LD2 motif<br /> | **[[3u3f]] – hFAK2 FAT domain (mutant) + paxillin LD2 motif<br /> | ||
- | *''' | + | *'''CapAB tyrosine kinase''' |
- | **[[ | + | **[[3bfv]] - SaTK CapA1/CapB2 – ''Staphylococcus aureus'' <br /> |
- | **[[ | + | **[[2ved]] - SaTK CapA1/CapB2 + Mg + ADP |
- | * ''' | + | *'''Fer tyrosine kinase''' |
- | * | + | **[[2kk6]] - hTK Fer SH2 domain – NMR<BR /> |
+ | **[[6kc4]] - hTK Fer SH2 domain + phosphopeptide<BR /> | ||
- | * | + | *'''Ptk6 tyrosine kinase or breast tumor kinase Brk''' |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | * | + | **[[1rja]] - hTK Ptk6 SH2 domain – NMR<br /> |
+ | **[[2kgt]] - hTK Ptk6 SH3 domain – NMR<br /> | ||
+ | **[[5d7v]], [[6cz2]] - hTK Ptk6 kinase domain <br /> | ||
+ | **[[5da3]], [[6cz3]], [[6cz4]] - hTK Ptk6 kinase domain + inhibitor<br /> | ||
+ | **[[5h2u]] - hTK Ptk6 kinase domain (mutant) + cancer drug<br /> | ||
- | * | + | *'''Ptk7 tyrosine kinase or inactive tyrosine-protein kinase 7''' |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | * | + | **[[6vg3]] - hTK Ptk7 kinase domain <br /> |
- | * | + | *'''PtkA tyrosine kinase''' |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | * | + | **[[6f2x]] - TK PtkA – ''Mycobacterium tuberculosis'' - NMR<br /> |
- | * | + | *'''Lyn tyrosine kinase''' (Domains: SH3 39-101; SH2 115-229; kinase 239-512) |
- | * | + | **[[4tzi]] - hTK Lyn SH2 domain <br /> |
+ | **[[6nmw]] - hTK Lyn SH3 domain <br /> | ||
+ | **[[1w1f]] - hTK Lyn SH3 domain – NMR<br /> | ||
+ | **[[1wa7]] - hTK Lyn SH3 domain + peptide – NMR<br /> | ||
+ | **[[3a4o]] - hTK Lyn residues 233-512 + staurosporine<br /> | ||
+ | **[[5xy1]] - hTK Lyn kinase domain + inhibitor<br /> | ||
+ | **[[2zv7]] - mTK Lyn kinase domain<br /> | ||
+ | **[[2zv8]] - mTK Lyn kinase domain + AMPPNP<br /> | ||
+ | **[[2zv9]] - mTK Lyn kinase domain + PP2<br /> | ||
+ | **[[2zva]] - mTK Lyn kinase domain + cancer drug<br /> | ||
- | * | + | *'''Txk tyrosine kinase''' |
- | + | ||
- | + | ||
- | + | ||
- | * | + | **[[2dm0]] - hTK Txk SH2 domain – NMR<br /> |
- | * | + | *'''Yes tyrosine kinase''' |
- | + | ||
- | + | ||
- | * | + | **[[2hda]] - hTK Yes SH3 domain <br /> |
+ | **[[5mtj]] - hTK Yes SH2 domain + monobody<br /> | ||
- | * | + | *'''Tec tyrosine kinase''' |
- | * | + | **[[2lul]] - hTK Tec PH domain - NMR<br /> |
+ | **[[1gl5]] - hTK Tec SH3 domain - NMR<br /> | ||
- | * | + | *'''Fes/Fps tyrosine kinase''' |
- | * | + | **[[1wqu]], [[2dcr]] - hTK Fes SH2 domain - NMR<br /> |
+ | **[[3bkb]] - hTK Fes SH2+kinase domain - NMR<br /> | ||
+ | **[[4dyl]] - hTK Fes F-Bar domain <br /> | ||
+ | **[[3cbl]] - hTK Fes SH2+kinase domain + peptide<br /> | ||
+ | **[[3cd3]] - hTK Fes SH2+kinase domain + peptide + staurosporine<br /> | ||
+ | **[[4e93]], [[6jmf]] - hTK TFes + inhibitor<br /> | ||
- | * | + | *'''Etk tyrosine kinase''' |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | *'' | + | **[[3cio]] - EcTK Etk kinase domain – ''Escherichia coli''<br /> |
- | * | + | *'''Wzc tyrosine kinase''' |
- | + | ||
- | * | + | **[[3la6]] - EcTK Wzc kinase domain <br /> |
+ | **[[7ni2]], [[7nib]] - EcTK Wzc – Cryo EM <br /> | ||
+ | **[[7dhd]] - VvTK Wzc – Vibrio vulnificus <br /> | ||
+ | **[[7dhe]], [[7dhf]] - VvTK Wzc + inhibitor <br /> | ||
- | * | + | *'''Ros tyrosine kinase''' |
- | * | + | **[[3zbf]] - hTK Ros kinase domain + cancer drug<br /> |
+ | **[[4uxl]] - hTK Ros kinase domain + inhibitor<br /> | ||
- | **[[5f20]], [[5f1z]], [[6ova | + | *'''Non-receptor Tyk2 tyrosine kinase''' (Domains: SH2+FERM 23-540; pseudokinase 541-880; kinase 880-1170) |
+ | |||
+ | **[[5f20]], [[5f1z]], [[6ova]] - hTK Tyk2 kinase domain + inhibitor<br /> | ||
**[[3lxn]], [[3lxp]], [[3nyx]], [[3nz0]], [[4e1z]], [[4e20]], [[4gfo]], [[4gih]], [[4gii]], [[4gj2]], [[4gj3]], [[4py1]], [[5wal]], [[5wev]], [[6dbk]], [[6dbm]] - hTK Tyk2 kinase domain (mutant) + inhibitor<br /> | **[[3lxn]], [[3lxp]], [[3nyx]], [[3nz0]], [[4e1z]], [[4e20]], [[4gfo]], [[4gih]], [[4gii]], [[4gj2]], [[4gj3]], [[4py1]], [[5wal]], [[5wev]], [[6dbk]], [[6dbm]] - hTK Tyk2 kinase domain (mutant) + inhibitor<br /> | ||
- | **[[6aam]], [[6x8g]], [[6x8f]] - hTK Tyk2 kinase domain (mutant) + | + | **[[6aam]], [[6x8g]], [[6x8f]] - hTK Tyk2 kinase domain (mutant) + drug<br /> |
**[[4gvj]] - hTK Tyk2 kinase domain (mutant) + ADP<br /> | **[[4gvj]] - hTK Tyk2 kinase domain (mutant) + ADP<br /> | ||
**[[4oli]] - hTK Tyk2 pseudokinase + kinase domains <br /> | **[[4oli]] - hTK Tyk2 pseudokinase + kinase domains <br /> | ||
**[[3zon]], [[5c01]], [[5c03]] - hTK Tyk2 pseudokinase domain <br /> | **[[3zon]], [[5c01]], [[5c03]] - hTK Tyk2 pseudokinase domain <br /> | ||
- | **[[4wov]], [[5tkd]], [[6nzr]], [[6nzq]], [[6nzp]], [[6nzh]], [[6nzf]], [[6nze]], [[6nsl]] - hTK Tyk2 pseudokinase domain + inhibitor<br /> | + | **[[4wov]], [[5tkd]], [[6nzr]], [[6nzq]], [[6nzp]], [[6nzh]], [[6nzf]], [[6nze]], [[6nsl]], [[7ax4]], [[7k7o]], [[7k7q]] - hTK Tyk2 pseudokinase domain + inhibitor<br /> |
**[[4po6]] - hTK Tyk2 SH2+FERM domains + IFNAR1 peptide<br /> | **[[4po6]] - hTK Tyk2 SH2+FERM domains + IFNAR1 peptide<br /> | ||
- | *''' | + | *'''Hck tyrosine kinase''' Domains: SH3 81-137; SH2 119-224; SH1 or kinase+C-terminal 225-525; |
- | **[[ | + | **[[3hck]] - hTK SH2 domain - NMR<BR /> |
+ | **[[1bu1]] - hTK SH3 domain <BR /> | ||
+ | **[[4hck]], [[5hck]] - hTK SH3 domain - NMR<BR /> | ||
+ | **[[2oj2]], [[2oi3]] - hTK SH3 domain + peptide - NMR<BR /> | ||
+ | **[[3rbb]], [[3rea]], [[3reb]] - hTK SH3 domain (mutant) + HIV NEF<BR /> | ||
+ | **[[5nuh]] - hTK SH3 domain + SIV NEF<BR /> | ||
+ | **[[4orz]] - hTK SH3 domain (mutant) + HIV NEF + single domain antibody<br /> | ||
+ | **[[3nhn]] - hTK SH3-SH2-linker domain <BR /> | ||
+ | **[[4u5w]] - hTK Hck SH3-SH2 domains + NEF <br /> | ||
+ | **[[2c0i]], [[2c0o]], [[2c0t]] - hTK SH3-SH2-SH1 domain + inhibitor<BR /> | ||
+ | **[[5h0b]], [[5h0e]], [[5h0g]], [[5h0h]] - hTK SH3-SH2-SH1 domain (mutant) + inhibitor<BR /> | ||
+ | **[[2hk5]], [[5zj6]] - hTK kinase domain + inhibitor<BR /> | ||
+ | **[[1qcf]], [[3vrz]], [[3vs0]], [[3vs3]], [[3vs4]], [[3vs5]], [[3vs6]], [[3vs7]] - hTK SH3-SH2-kinase-C-terminal domain + inhibitor<BR /> | ||
+ | **[[3vry]], [[3vs1]], [[3vs2]] - hTK SH3-SH2-kinase-C-terminal domain (mutant) + inhibitor<BR /> | ||
+ | **[[1ad5]] - hTK SH3-SH2-kinase-C-terminal domain + AMPPNP<BR /> | ||
+ | **[[2hck]] - hTK SH3-SH2-kinase-C-terminal domain + quercetin<BR /> | ||
+ | **[[4lud]], [[4lue]] - hTK SH2+SH3+kinase+C-terrminal domain (mutant) + fluorescent compound<br /> | ||
- | *''' | + | *'''Ack1 tyrosine kinase''' or activated cdc42 kinase 1 |
- | **[[ | + | **[[1u46]], [[4hzr]] - hTK Ack1 kinase domain 115-389<br /> |
- | **[[ | + | **[[4hzs]] - hTK Ack1 kinase+SH3 domains <br /> |
+ | **[[1u4d]], [[3eqp]], [[3eqr]], [[4ewh]], [[4id7]], [[5zxb]], [[7kp6]], [[8hmt]] - hTK Ack1 kinase domain + inhibitor<br /> | ||
+ | **[[8fe9]] - hTK Ack1 kinase domain (mutant) + inhibitor<br /> | ||
- | *'''Zap-70 tyrosine kinase''' (Domains: SH2 1-259; kinase 327-606 | ||
- | |||
- | **[[4k2r]] – hTK Zap-70<br /> | ||
- | **[[2ozo]] - hTK Zap-70 (mutant) <br /> | ||
- | **[[1m61]] - hTK Zap-70 SH2 domain | ||
- | |||
- | *Zap-70 complex | ||
- | |||
- | **[[2oq1]], [[4xz1]] - hTK Zap-70 SH2 domain + peptide<br /> | ||
- | **[[4xz0]] - hTK Zap-70 SH2 domain + inhibitor<br /> | ||
- | **[[1u59]] - hTK Zap-7kinase domain + staurosporine | ||
- | **[[2zva]] - mTK Lyn kinase domain + cancer drug<br /> | ||
*'''RECEPTOR TYROSINE KINASES - RTK''' | *'''RECEPTOR TYROSINE KINASES - RTK''' | ||
- | * | + | *Burton’s tyrosine kinase (Domains: PH 1-170; SH3 216-273; SH2 273-378; kinase 378-659) |
+ | **[[8gmb]] - hTK Btk <br /> | ||
**[[2z0p]] - hTK Btk PH domain<br /> | **[[2z0p]] - hTK Btk PH domain<br /> | ||
- | **[[1btk | + | **[[1btk]] – hTK Btk PH domain (mutant) <br /> |
**[[3p08]], [[1k2p]] - hTK Btk kinase domain<br /> | **[[3p08]], [[1k2p]] - hTK Btk kinase domain<br /> | ||
**[[1aww]], [[1awx]], [[1qly]] - hTK Btk SH3 domain – NMR<BR /> | **[[1aww]], [[1awx]], [[1qly]] - hTK Btk SH3 domain – NMR<BR /> | ||
Line 428: | Line 423: | ||
**[[4xi2]] - hTK Btk SH3-SH2-kinase domain<br /> | **[[4xi2]] - hTK Btk SH3-SH2-kinase domain<br /> | ||
**[[4y95]] - bTK Btk kinase domain (mutant) - bovine<br /> | **[[4y95]] - bTK Btk kinase domain (mutant) - bovine<br /> | ||
- | **[[4y93]] - bTK Btk PH+kinase domains (mutant) <br /> | + | **[[4y93]], [[8s93]] - bTK Btk PH+kinase domains (mutant) <br /> |
*Btk complex | *Btk complex | ||
**[[1b55]] - hTK Btk PH domain + inositol-tetrakisphosphate<br /> | **[[1b55]] - hTK Btk PH domain + inositol-tetrakisphosphate<br /> | ||
- | **[[6tse]], [[6tvn]] - hTK Btk PH domain (mutant) + indoline derivative<br /> | ||
**[[1bwn]] - hTK Btk PH domain (mutant) + inositol-tetrakisphosphate<br /> | **[[1bwn]] - hTK Btk PH domain (mutant) + inositol-tetrakisphosphate<br /> | ||
- | **[[ | + | **[[6yyf]], [[6yyg]], [[6yyk]] - hTK Btk PH domain (mutant) + inhibitor<br /> |
- | **[[3gen]], [[3ocs]], [[3pix]], [[3piy]], [[3piz]], [[3pj1]], [[3pj2]], [[3pj3]], [[4nwm]], [[ | + | **[[3gen]], [[3ocs]], [[3pix]], [[3piy]], [[3piz]], [[3pj1]], [[3pj2]], [[3pj3]], [[4nwm]], [[4rx5]], [[4yhf]], [[4z3v]], [[4zly]], [[4zlz]], [[5bpy]], [[5bq0]], [[5fbn]], [[5fbo]], [[5j87]], [[5jrs]], [[5kup]], [[5p9f]], [[5p9g]], [[5p9h]], [[5p9i]], [[5p9j]], [[5p9k]], [[5p9l]], [[5p9m]], [[5t18]], [[5u9d]], [[5vfi]], [[5vgo]], [[5xyz]], [[5zz4]], [[6aua]], [[6aub]], [[6bik]], [[6bke]], [[6bkh]], [[6bkw]], [[6bln]], [[6di0]], [[6di1]], [[6di3]], [[6di5]], [[6di9]], [[6e4f]], [[6e9p]], [[6n9p]], [[6nzm]], [[6nfh]], [[6nfi]], [[6o8i]], [[6s90]], [[6tfp]], [[6vxq]], [[6w06]], [[6w07]], [[6x3n]], [[6x3o]], [[6x3p]], [[6xe4]], [[7kxl]], [[7kxm]], [[7kxn]], [[7kxo]], [[7kxp]], [[7kxq]], [[7lty]], [[7ltz]], [[7n4q]], [[7n4r]], [[7n4s]], [[7n5o]], [[7n5r]], [[7n5x]], [[7n5y]], [[7r60]], [[7r61]], [[7yc9]], [[8e2m]], [[8ejb]], [[8flg]], [[8flh]], [[8flv]], [[8gc7]] - hTK Btk kinase domain + inhibitor<br /> |
- | **[[3k54]], [[3t9t]], [[4ot5]], [[4ot6]], [[4otq]], [[4otr]], [[4otf]], [[4rfy]], [[4rfz]], [[4rg0]], [[6ep9]], [[6hrt]], [[6hrp]] - hTK Btk kinase domain (mutant) + inhibitor<br /> | + | **[[3k54]], [[3t9t]], [[4ot5]], [[4ot6]], [[4otq]], [[4otr]], [[4otf]], [[4rfy]], [[4rfz]], [[4rg0]], [[6ep9]], [[6hrt]], [[6hrp]], [[8ff0]], [[8gc8]] - hTK Btk kinase domain (mutant) + inhibitor<br /> |
- | **[[5vgo]], [[ | + | **[[6w7o]], [[6w8i]], [[8dso]] - hTK Btk kinase domain + cIAP + inhibitor<br /> |
- | **[[3oct]] - hTK Btk kinase domain (mutant) + cancer drug<br /> | + | **[[5vgo]], [[7l5o]], [[7l5p]], [[8fll]], [[8u2d]], [[8u2e]] - hTK Btk kinase domain + cancer drug<br /> |
+ | **[[3oct]], [[8fd9]], [[8fln]] - hTK Btk kinase domain (mutant) + cancer drug<br /> | ||
**[[6omu]] - hTK Btk kinase domain + MS drug<br /> | **[[6omu]] - hTK Btk kinase domain + MS drug<br /> | ||
**[[6j6m]] - hTK Btk kinase domain + MCL drug<br /> | **[[6j6m]] - hTK Btk kinase domain + MCL drug<br /> | ||
Line 447: | Line 442: | ||
*'''c-FMS tyrosine kinase or macrophage colony-stimulating factor 1 receptor''' see [[Colony-stimulating factor receptor]] | *'''c-FMS tyrosine kinase or macrophage colony-stimulating factor 1 receptor''' see [[Colony-stimulating factor receptor]] | ||
- | + | *'''Kit tyrosine kinase''' or mast/stem cell growth factor receptor Kit; Domains – extracellular 1-519; kinase 547-693, 754-935 | |
- | + | ||
- | *'''Kit tyrosine kinase''' or | + | |
**[[2ec8]] - hTK Kit extracellular domain<br /> | **[[2ec8]] - hTK Kit extracellular domain<br /> | ||
+ | **[[3g0e]], [[3g0f]] - hTK Kit kinase domain (mutant) + cancer drug<br /> | ||
**[[2e9w]] - hTK Kit extracellular domain + stem cell factor<br /> | **[[2e9w]] - hTK Kit extracellular domain + stem cell factor<br /> | ||
**[[1t45]], [[4pgz]] - hTK Kit kinase domain<br /> | **[[1t45]], [[4pgz]] - hTK Kit kinase domain<br /> | ||
- | **[[1t46]], [[4u0i]], [[ | + | **[[1t46]], [[4u0i]], [[6kia]], [[6mob]] - hTK Kit kinase domain + cancer drug<br /> |
- | **[[6gqj | + | **[[6gqj]], [[6gqk]], [[6gql]], [[6gqm]] - hTK Kit kinase domain (mutant) + cancer drug<br /> |
- | **[[6itv]], [[6itt]], [[6xv9]], [[6xva]], [[6xvb]] - hTK Kit kinase domain + inhibitor<br /> | + | **[[6itv]], [[6itt]], [[6xv9]], [[6xva]], [[6xvb]], [[7khg]], [[7khj]], [[7khk]] - hTK Kit kinase domain + inhibitor<br /> |
**[[4hvs]], [[6hh1]] - hTK Kit kinase domain (mutant) + inhibitor<br /> | **[[4hvs]], [[6hh1]] - hTK Kit kinase domain (mutant) + inhibitor<br /> | ||
**[[2o26]] - hTK Kit residues 25-314 + Kit ligand<br /> | **[[2o26]] - hTK Kit residues 25-314 + Kit ligand<br /> | ||
Line 464: | Line 458: | ||
**[[2dbj]] - hTK Mer FN3 domain – NMR<BR /> | **[[2dbj]] - hTK Mer FN3 domain – NMR<BR /> | ||
- | **[[2p0c]] - hTK Mer kinase domain | + | **[[2p0c]] - hTK Mer kinase domain<br /> |
*Mer complex | *Mer complex | ||
Line 471: | Line 465: | ||
**[[3brb]] - hTK Mer kinase domain + ADP<br /> | **[[3brb]] - hTK Mer kinase domain + ADP<br /> | ||
**[[2p0c]] - hTK Mer kinase domain + ANP<br /> | **[[2p0c]] - hTK Mer kinase domain + ANP<br /> | ||
- | **[[3bpr]], [[3tcp]], [[4m3q]], [[4mh7]], [[4mha]], [[ | + | **[[3bpr]], [[3tcp]], [[4m3q]], [[4mh7]], [[4mha]], [[5k0k]], [[5k0x]], [[5tc0]], [[5td2]], [[5u6c]], [[6mep]], [[7avx]], [[7aw4]], [[7cqe]], [[7m5z]], [[7oam]], [[7ols]], [[7olv]], [[7olx]] - hTK Mer kinase domain + inhibitor<br /> |
- | **[[7ab2]], [[7aax]], [[7aaz]] - hTK Mer kinase domain (mutant) + inhibitor<br /> | + | **[[7ab2]], [[7aax]], [[7aaz]], [[7avy]], [[7avz]], [[7aw0]], [[7aw1]], [[7aw2]], [[7aw3]], [[7dxl]], [[7xhy]] - hTK Mer kinase domain (mutant) + inhibitor<br /> |
**[[7ab1]] - hTK Mer kinase domain + anti-cancer drug<br /> | **[[7ab1]] - hTK Mer kinase domain + anti-cancer drug<br /> | ||
**[[7aay]] - hTK Mer kinase domain (mutant) + anti-cancer drug<br /> | **[[7aay]] - hTK Mer kinase domain (mutant) + anti-cancer drug<br /> | ||
Line 487: | Line 481: | ||
*'''ErbB tyrosine kinase''' see [[Epidermal Growth Factor Receptor]] | *'''ErbB tyrosine kinase''' see [[Epidermal Growth Factor Receptor]] | ||
- | |||
- | *'''MuSK tyrosine kinase''' or '''muscle skeleton receptor tyrosine kinase''' | ||
- | |||
- | **[[3hkl]] - rTK MuSK Fz-Crd domain <br /> | ||
- | **[[1luf]], [[2iep]] - rTK MuSK cytoplasmic domain <br /> | ||
*'''Sgk223 tyrosine kinase or sugen kinase''' | *'''Sgk223 tyrosine kinase or sugen kinase''' | ||
Line 497: | Line 486: | ||
**[[5ve6]] - hTK <br /> | **[[5ve6]] - hTK <br /> | ||
- | *'''Matk tyrosine kinase''' or | + | *'''Matk tyrosine kinase''' or megakaryocyte-associated tyrosine-protein kinase |
**[[3us4]] - hTK Matk SH2 domain <br /> | **[[3us4]] - hTK Matk SH2 domain <br /> | ||
+ | **[[1x6g]] - hTK Matk SH3 domain - NMR<br /> | ||
- | + | *'''Flt3 tyrosine kinase''' | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | *'''Flt3 tyrosine kinase''' | + | |
**[[1rjb]] - hTK Flt3 kinase domain <br /> | **[[1rjb]] - hTK Flt3 kinase domain <br /> | ||
- | **[[4rt7]], [[ | + | **[[4rt7]], [[5x02]], [[6il3]] - hTK Flt3 kinase domain + inhibitor<br /> |
- | **[[ | + | **[[6jqr]] - hTK Flt3 kinase domain + leukemia drug<br / |
- | **[[ | + | **[[4xuf]] - hTK Flt3 kinase domain (mutant) + leukemia drug<br /> |
+ | **[[3qs7]], [[3qs9]] - hTK Flt3 kinase domain + SL cytokine<br / | ||
*'''Tie2 tyrosine kinase''' | *'''Tie2 tyrosine kinase''' | ||
Line 521: | Line 503: | ||
**[[1fvr]] - hTK Tie2 kinase domain <br /> | **[[1fvr]] - hTK Tie2 kinase domain <br /> | ||
- | *''' | + | *'''DDR1 and DDR2 tyrosine kinase receptors''' see [[Epithelial discoidin domain-containing receptor]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
*'''c-Met tyrosine kinase''' see [[Hepatocyte growth factor receptor]] | *'''c-Met tyrosine kinase''' see [[Hepatocyte growth factor receptor]] | ||
Current revision
3D structures of tyrosine kinase
Updated on 01-March-2024 - For a general description of the protein see Tyrosine kinase